Alicia completed a PhD in Biochemistry and Molecular Biology at Melbourne University in 2003 and subsequently worked as a post-doctoral fellow for many years in the US and Europe where she was focused on understanding signal transduction pathways in neurology and oncology. She has since retrained as a Nuclear Medicine Technologist allowing her to bring her extensive research skills into the clinical Nuclear Medicine realm.
Alicia is currently employed at the Peter MacCallum Cancer Centre where she is the lead Nuclear Medicine Technologist responsible for research conducted on the Total Body PET. Alicia has experience coordinating with clinical trials teams and other imaging societies such as ARTnet and SNMMI to qualify and maintain imaging equipment for research. She has also developed imaging protocols and been involved in numerous molecular imaging and radionuclide therapy clinical trials. Her passion is to expand the use of molecular biology to identify new biomarkers that can be exploited to create new radiopharmaceuticals to advance theranostics in oncology.
NIF is delighted to congratulate its long-term partner, the Australian Epilepsy Project (AEP), on securing $30 million in Australian Government funding through the Medical Research Future Fund. The pr
28 May 2026
The University of Melbourne officially launched a cutting-edge instrument to capture high temporal resolution brain activity in a new facility that is the first of its kind in the southern hemisphere.
08 May 2026
Monash University and The Alfred announced the launch of The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) to tackle major challenges in cancer immunotherapy by bette
30 April 2026
For some, the colonisation of Mars may seem like futuristic science fiction. However, neuroscientists and neuroradiologists – such as NIF user Monash University’s Professor Meng Law, NIF’s SAHMR
01 April 2026